Vitamin D levels and presence of AMD are not associated

Article

Recent evidence suggesting a link between low vitamin D levels, delayed angiogenesis and reduced inflammatory response has been disproved.

Recent evidence suggesting a link between low vitamin D levels, delayed angiogenesis and reduced inflammatory response has been disproved in a study featured in Eye.

A cross-sectional clinical study led by Dr S. Golan, Department of Ophthalmology, Tel Aviv Sourasky Medical Center, Israel, looked at 1045 members of the Maccabi Healthcare Services (MHS) with age-related macular degeneration (AMD) and 8124 patients who didn't have AMD. All participants had their Vitamin D levels taken during routine examinations between 2000 and 2008. The main outcome measure was Serum 25-OH vitamin D levels.

The findings demonstrated a mean ±SD level of 25-OH vitamin D of 24.1±9.41 ng/ml for AMD patients and 24.13±9.50 ng/ml for non-AMD patients. A third of AMD patients and 32.86% of the controls had vitamin D levels of under 16 ng/ml, and the proportions of examinations in which the vitamin D level was greater than 74 ng/ml were 0.19 and 0.14%, respectively.

The results suggest the study has disproved a recent investigation into the association between reduced vitamin D levels and presence of AMD.

Related Videos
Ana Neves, head of global marketing for ZEISS Meditec Ophthalmology
Fritz Hengerer, MD, PhD, Director, Eye Hospital at Bürgerhospital, Frankfurt, Germany
Dr Sheng Lim, professor of glaucoma studies at St Thomas' Hospital, London
Kasperi Kankare at the iCare booth at ESCRS
Scott D Barnes, MD, CMO of STAAR Surgical
Tomislav Bucalic, head of marketing at Geuder, and David Geuder, member of the executive board and CIO
Colman Cawe, director of fundraising and communications, Orbis UK
Related Content
© 2023 MJH Life Sciences

All rights reserved.